Funding for this research was provided by:
Pfizer Pharmaceuticals Korea Ltd. (A3921304: RA satisfaction NIS, A3921304: RA satisfaction NIS, A3921304: RA satisfaction NIS)
Received: 14 October 2022
Accepted: 6 April 2023
First Online: 27 April 2023
: This study complies with the Declaration of Helsinki. Furthermore, the locally appointed Institutional Review Board of each participating center has approved the research protocol. All participants voluntarily signed written consent forms.
: Not applicable.
: The authors do not have an actual or potential conflict of interest and do not have any interest to declare with regard to this work. SH Lee, JY Jeon, and HJ Yoo are employed by Pfizer.